Profile
RAPP VRTX REGN ALNY SGEN ARGX
Company Name Rapport Therapeutics, Inc. Common Stock Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $511.33M $117.98B $60.26B $43.28B $43.15B $34.40B
Employees 0.07K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Abraham N. Ceesay Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
RAPP VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 2 4 1 3 2
Quant Rating Sell Sell Buy Strong Sell Neutral Sell
Trading
RAPP VRTX REGN ALNY SGEN ARGX
Last Close $14.6 $468.85 $567.74 $314.94 $228.74 $560.24
High 52 $29.23 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $7.15 $396.64 $482.92 $224.58 $228.74 $461.01
Price vs. 52 Week High -50.05 % -9.27 % -52.76 % -5.11 % 0 % -16.6 %
Price vs. 52 Week Low 104.2 % 18.21 % 17.56 % 40.24 % 0 % 21.52 %
Total Return
RAPP VRTX REGN ALNY SGEN ARGX
1 Month Return 31.06 % 1.91 % 8.81 % 3.37 % 0 % -4.52 %
3 Month Return 57.67 % -3.17 % 2.45 % 32.46 % 0 % -3.56 %
6 Month Return -1.42 % 14.48 % -18.53 % 32.34 % 0 % -14.63 %
9 Month Return -33.79 % -2.67 % -44.1 % 10.77 % 0 % 4.39 %
YTD Return -17.7 % 16.43 % -20.3 % 33.84 % 0 % -8.9 %
1 Year Return -41.13 % -4.07 % -48.39 % 20.89 % 0 % 20.11 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
RAPP VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.31 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -41.53 % -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
RAPP VRTX REGN ALNY SGEN ARGX
Asset Growth 102.63 % -0.87 % 36.55 %
Gross Profit Growth 100 % 10.25 % 77.08 %
Revenue Growth - 11.66 % 78.6 %
Revenue 3 Year - 45.6 % 275.84 %
Revenue 5 Year - 163.93 % 1701.04 %
Revenue 10 Year - 1632.15 % 5950.81 %
EBIT Growth -125.18 % -93.69 % 128.87 %
Net Income Growth -125.11 % -114.8 % 382.34 %
Net Income 3 Yeari Growth Per Share -613.12 % -122.89 % 274.39 %
Net Income 5 Yeari Growth Per Share -613.12 % -145.38 % 396.61 %
Net Income 10 Yeari Growth Per Share -613.12 % 33.84 % 938.02 %
Operating Income Growth -129.57 % -106.08 % 94.91 %
Operating Cash Flow Growth (CFG) -138.5 % -113.93 % 80.31 %
Operating 3 Year CFG -1839.72 % -118.65 % 88.36 %
Operating 5 Year CFG -1839.72 % -131.3 % -135.21 %
Operating 10 Year CFG -1839.72 % 12.43 % -64 %
EPS Growth -100 % -114.8 % 369.77 %
EPS Diluted Growth -100 % -114.97 % 347.67 %
Book Value Per Share 88.91 % -6.59 % 28.16 %
Share Holder 3 Year Equity Growth Per Share 1418.98 % 62.6 % 85.14 %
Share Holder 5 Year Equity Growth Per Share 1418.98 % 168.85 % 200.53 %
Share Holder 10 Year Equity Growth Per Share 1418.98 % 1265.7 % 1039.11 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -31.22 % 116.42 % 95.27 %
Free Cash Flow Growth -133.31 % -124.1 % 67.46 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
RAPP VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -26.39 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM -25.48 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM -31.8 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 85.64 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -860.11 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM 0.1 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM - 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM - 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -0.19 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -0.2 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 80.92 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.41 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -860.11 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -7.4 -93.78 19.95 -574.08 -81.26 -443.33
Price To Operating Cash Flows Ratio TTM -73.25 -120.39 15.32 -954.11 -93.1 -526.76
Price Cash Flow Ratio TTM -73.25 -120.39 15.32 -954.11 -93.1 -526.76
Income Statement (TTM)
RAPP VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $0B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.08B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.08B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -0.38 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
RAPP VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.01B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $0.31B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0.25B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.31B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
RAPP VRTX REGN ALNY SGEN ARGX
Net Income $-0.08B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 38.24
AARD Aardvark Therapeutics, Inc. Common Stock 12.17
ABCL AbCellera Biologics Inc. 4.01
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.74
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.4
ABPWW 0.0351
ABSI Absci Corporation 2.67
ABUS Arbutus Biopharma Corporation 3.17
ABVC ABVC BioPharma, Inc. 3.97
ABVX Abivax SA American Depositary Shares 8.27
ACAD ACADIA Pharmaceuticals Inc. 20.98
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7495
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.32
ACIU AC Immune SA 2.04
ETFs With Exposure to RAPP
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00792 221.7
VTI Vanguard Total Stock Market Index Fund 0 307.02
IBB iShares Biotechnology ETF 0.02407 131.59
SCHB Schwab U.S. Broad Market ETF 0.000260963 24.07
SCHA Schwab U.S. Small-Cap ETF 0.00262959 25.93
IWN iShares Russell 2000 Value ETF 0.01638 164.96
IWO iShares Russell 2000 Growth ETF 0.00825 288.65
VHT Vanguard Health Care Index Fund 0.00245 249.12
BIB ProShares Ultra Nasdaq Biotechnology 0.0330629 49.72
VXF Vanguard Extended Market Index Fund 0.00095 195.91
HDG ProShares Hedge Replication ETF 0.0010718 49.95
BBC Virtus LifeSci Biotech Clinical Trials ETF 0.85 21.19
UWM ProShares Ultra Russell2000 0.00614277 39.68
VTHR Vanguard Russell 3000 Index Fund 0.00013 275.3
IWC iShares Micro-Cap ETF 0.05552 131.83
URTY ProShares UltraPro Russell2000 0.00492453 42.39
VTWV Vanguard Russell 2000 Value Index Fund 0.00539 145.415
ISCB iShares Morningstar Small-Cap ETF 0.00217 59.7561
SBIO ALPS Medical Breakthroughs ETF 0.0029 32.28
VTWG Vanguard Russell 2000 Growth Index Fund 0.00602 210.86
VTWO Vanguard Russell 2000 Index Fund 0.00547 89.59
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0.01 42.41
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00031 104.43
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 104.41
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 49.99
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 49.98
VBINX Vanguard Balanced Index Fund Investor Shares 0 49.99
BOUT Innovator IBD Breakout Opportunities ETF 1.72 36.38
IBBQ Invesco Nasdaq Biotechnology ETF 0.048 22.01
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.0493 5.513
VTSAX Vanguard Total Stock Market Index Fund 0 149.48
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.0493 6.44
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00095 148.65
VITSX Vanguard Total Stock Market Index Fund 0 149.5
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.0493 6.421
IBRN iShares Neuroscience and Healthcare ETF 0.51042 23.2009
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00095 148.66
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.0493 4.7715
USFM.L UBS (Irl) ETF plc - MSCI USA Select Factor Mix UCITS ETF (USD) A-dis 0 2676.5
VHCIX Vanguard HealthCare Index Fund Admiral Shs 0.00245 124.7
USUE.DE UBS (Irl) ETF plc - MSCI USA Select Factor Mix UCITS ETF (USD) A-acc 0 34.2
JKJ iShares Morningstar Small-Cap ETF 0.00217 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 53.65
VEMPX Vanguard Extended Market Index InstlPlus 0.00095 366.83
USFMDN.MX UBS (Irl) ETF Public Limited Company - MSCI USA Select Factor Mix UCITS ETF 0 382
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 280.44
MNTL Tema Neuroscience and Mental Health ETF 0.18 23.1519
RSSL Global X Funds 0.01 87.09
RFLR Innovator ETFs Trust 0.03 25.845
Unlock